These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 18622176

  • 1. Food restriction and streptozotocin treatment decrease 5-HT1A and 5-HT2A receptor-mediated behavioral effects in rats.
    Li JX, France CP.
    Behav Pharmacol; 2008 Jul; 19(4):292-7. PubMed ID: 18622176
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS, Assié MB, Koek W.
    J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
    [Abstract] [Full Text] [Related]

  • 3. The 5-HT1A receptor full agonist, 8-OH-DPAT inhibits ACTH-induced 5-HT2A receptor hyperfunction in rats: involvement of 5-HT1A receptors in the DOI-induced wet-dog shakes in ACTH-treated rats.
    Kitamura Y, Kitagawa K, Fujitani Y, Shibata K, Araki H, Sendou T, Gomita Y.
    Biol Pharm Bull; 2007 Jan; 30(1):117-20. PubMed ID: 17202670
    [Abstract] [Full Text] [Related]

  • 4. Effects of 5-HT1A, 5-HT2A and 5-HT2C receptor agonists and antagonists on responding for a conditioned reinforcer and its enhancement by methylphenidate.
    Fletcher PJ, Zeeb FD, Browne CJ, Higgins GA, Soko AD.
    Psychopharmacology (Berl); 2017 Mar; 234(5):889-902. PubMed ID: 28097374
    [Abstract] [Full Text] [Related]

  • 5. Differential effects of 5-HT agonists and antagonists on the repeated acquisition and performance of response sequences in monkeys.
    Winsauer PJ, Moerschbaecher JM.
    Behav Pharmacol; 2000 Nov; 11(7-8):535-53. PubMed ID: 11198126
    [Abstract] [Full Text] [Related]

  • 6. Modification of behavioral effects of 8-hydroxy-2-(di-n-propylamino)tetralin following chronic ethanol consumption in the rat: evidence for the involvement of 5-HT1A receptors in ethanol dependence.
    Kleven M, Ybema C, Carilla E, Hamon M, Koek W.
    Eur J Pharmacol; 1995 Aug 15; 281(3):219-28. PubMed ID: 8521904
    [Abstract] [Full Text] [Related]

  • 7. Attenuation of 5-HT1A and 5-HT2 but not 5-HT1C receptor mediated behaviour in rats following chronic treatment with 5-HT receptor agonists, antagonists or anti-depressants.
    Berendsen HH, Broekkamp CL.
    Psychopharmacology (Berl); 1991 Aug 15; 105(2):219-24. PubMed ID: 1839064
    [Abstract] [Full Text] [Related]

  • 8. Desensitization of 5-HT1A receptors by 5-HT2A receptors in neuroendocrine neurons in vivo.
    Zhang Y, Gray TS, D'Souza DN, Carrasco GA, Damjanoska KJ, Dudas B, Garcia F, Zainelli GM, Sullivan Hanley NR, Battaglia G, Muma NA, Van de Kar LD.
    J Pharmacol Exp Ther; 2004 Jul 15; 310(1):59-66. PubMed ID: 15064330
    [Abstract] [Full Text] [Related]

  • 9. Serotonin receptor subtypes influence prolactin secretion in the turkey.
    Chaiseha Y, Kang SW, Leclerc B, Kosonsiriluk S, Sartsoongnoen N, El Halawani ME.
    Gen Comp Endocrinol; 2010 Jan 01; 165(1):170-5. PubMed ID: 19540238
    [Abstract] [Full Text] [Related]

  • 10. Serotonergic stimulation of the rat hypothalamo-pituitary-adrenal axis: interaction between 5-HT1A and 5-HT2A receptors.
    Mikkelsen JD, Hay-Schmidt A, Kiss A.
    Ann N Y Acad Sci; 2004 Jun 01; 1018():65-70. PubMed ID: 15240353
    [Abstract] [Full Text] [Related]

  • 11. Effects of 5-HT1A and 5-HT2A receptor stimulation on temporal differentiation performance in the fixed-interval peak procedure.
    Asgari K, Body S, Zhang Z, Fone KC, Bradshaw CM, Szabadi E.
    Behav Processes; 2006 Feb 28; 71(2-3):250-7. PubMed ID: 16098683
    [Abstract] [Full Text] [Related]

  • 12. Chronic imipramine treatment sensitizes 5-HT1A and 5-HT 2 A receptors in the dorsal periaqueductal gray matter: evidence from the elevated T-maze test of anxiety.
    Zanoveli JM, Nogueira RL, Zangrossi H.
    Behav Pharmacol; 2005 Nov 28; 16(7):543-52. PubMed ID: 16170231
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. 5-HT1A and muscarinic acetylcholine receptors jointly regulate passive avoidance behavior.
    Riekkinen P.
    Eur J Pharmacol; 1994 Sep 01; 262(1-2):77-90. PubMed ID: 7813581
    [Abstract] [Full Text] [Related]

  • 15. Receptor-genes cross-talk: effect of chronic 5-HT(1A) agonist 8-hydroxy-2-(di-n-propylamino) tetralin treatment on the expression of key genes in brain serotonin system and on behavior.
    Popova NK, Naumenko VS, Cybko AS, Bazovkina DV.
    Neuroscience; 2010 Aug 11; 169(1):229-35. PubMed ID: 20423722
    [Abstract] [Full Text] [Related]

  • 16. The relation of central 5-HT1A and 5-HT2 receptors: low dose agonist-induced selective tolerance in the rat.
    Pranzatelli MR, Pluchino RS.
    Pharmacol Biochem Behav; 1991 Jun 11; 39(2):407-13. PubMed ID: 1835098
    [Abstract] [Full Text] [Related]

  • 17. Genomic responses to 5-HT1A or 5-HT2A/2C receptor activation is differentially regulated in four regions of rat brain.
    Tilakaratne N, Friedman E.
    Eur J Pharmacol; 1996 Jun 27; 307(2):211-7. PubMed ID: 8832223
    [Abstract] [Full Text] [Related]

  • 18. Modulation of the behavioral effects of 8-OH-DPAT by estrogen and DOI.
    Maswood N, Uphouse L.
    Pharmacol Biochem Behav; 1997 Dec 27; 58(4):859-66. PubMed ID: 9408187
    [Abstract] [Full Text] [Related]

  • 19. 5-HT1A receptor agonist (8-OH-DPAT) and 5-HT2 receptor agonist (DOI) disrupt the non-cognitive performance of rats in a working memory task.
    Ruotsalainen S, MacDonald E, Koivisto E, Stefanski R, Haapalinna A, Riekkinen P, Sirviö J.
    J Psychopharmacol; 1998 Dec 27; 12(2):177-85. PubMed ID: 9694031
    [Abstract] [Full Text] [Related]

  • 20. Analysis of the 5-HT1A receptor involvement in passive avoidance in the rat.
    Misane I, Johansson C, Ogren SO.
    Br J Pharmacol; 1998 Oct 27; 125(3):499-509. PubMed ID: 9806333
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.